GE HealthCare Technologies Inc. $GEHC Shares Bought by Fifth Third Bancorp

Fifth Third Bancorp lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 292.9% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 131,506 shares of the company’s stock after buying an additional 98,038 shares during the quarter. Fifth Third Bancorp’s holdings in GE HealthCare Technologies were worth $9,361,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Auto Owners Insurance Co grew its position in shares of GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after acquiring an additional 33,629,559 shares during the period. Norges Bank purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter worth approximately $596,024,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter worth $533,655,000. Cynosure Group LLC raised its holdings in GE HealthCare Technologies by 21,045.4% in the 4th quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock valued at $358,055,000 after acquiring an additional 4,344,817 shares during the last quarter. Finally, Boston Partners acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at approximately $287,627,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 2.5%

Shares of GE HealthCare Technologies stock opened at $63.20 on Thursday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The company’s fifty day moving average is $63.56 and its two-hundred day moving average is $72.15. The company has a market capitalization of $28.75 billion, a P/E ratio of 15.12, a PEG ratio of 1.68 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. During the same period in the prior year, the company earned $1.01 earnings per share. The firm’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s payout ratio is 3.35%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on GEHC. BNP Paribas Exane cut their price objective on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st. Citigroup reissued a “neutral” rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 8th. BMO Capital Markets began coverage on shares of GE HealthCare Technologies in a research report on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 price target for the company. Wells Fargo & Company lowered their price objective on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research report on Thursday, April 30th. Finally, JPMorgan Chase & Co. lowered their target price on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research note on Thursday, April 30th. Ten equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $79.48.

Insider Activity at GE HealthCare Technologies

In related news, CFO James Saccaro purchased 3,310 shares of the business’s stock in a transaction dated Friday, May 1st. The stock was acquired at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the acquisition, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at $5,300,742.60. This trade represents a 3.93% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Peter J. Arduini bought 4,169 shares of the company’s stock in a transaction on Thursday, April 30th. The stock was bought at an average cost of $59.92 per share, with a total value of $249,806.48. Following the completion of the acquisition, the chief executive officer owned 259,424 shares of the company’s stock, valued at $15,544,686.08. This represents a 1.63% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 21,847 shares of company stock worth $1,361,355 in the last three months. 0.36% of the stock is currently owned by corporate insiders.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.